.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Queensland Health
UBS
Merck
AstraZeneca
Argus Health
Johnson and Johnson
Dow
Colorcon

Generated: July 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018074

« Back to Dashboard
NDA 018074 describes PHENDIMETRAZINE TARTRATE, which is a drug marketed by Sandoz, Vitarine, Usl Pharma, Graham Dm, Ivax Pharms, Mfg Chemists, Nexgen Pharma Inc, Kv Pharm, Barr, Ferndale Labs, Inwood Labs, Tg United Labs, Kvk Tech, Mikart, Elite Labs Inc, Watson Labs, Ivax Sub Teva Pharms, Numark, Solvay, and Pvt Form, and is included in sixty-four NDAs. It is available from twenty-one suppliers. Additional details are available on the PHENDIMETRAZINE TARTRATE profile page.

The generic ingredient in PHENDIMETRAZINE TARTRATE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.

Summary for NDA: 018074

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 018074

Suppliers and Packaging for NDA: 018074

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PHENDIMETRAZINE TARTRATE
phendimetrazine tartrate
CAPSULE, EXTENDED RELEASE;ORAL 018074 NDA Eon Labs, Inc. 0185-5254 0185-5254-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0185-5254-01)
PHENDIMETRAZINE TARTRATE
phendimetrazine tartrate
CAPSULE, EXTENDED RELEASE;ORAL 018074 NDA Eon Labs, Inc. 0185-5254 0185-5254-10 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0185-5254-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength105MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
UBS
McKinsey
Johnson and Johnson
Cerilliant
AstraZeneca
McKesson
Chubb
Healthtrust
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot